Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
If implementation of DOTS-plus
a strategy using second line drugs to
treat patients with drug resistant tuberculosis
were optimal, fewer
deaths from tuberculosis would occur than with optimal DOTS (the
directly observed treatment, short course; WHO's recommended
tuberculosis treatment plan). In a decision analysis, Sterling and
colleagues (p 574) found that if DOTS-plus decreased the effectiveness
of DOTS even slightly (by 5%), more deaths from tuberculosis would
occur than under DOTS. The authors state that if DOTS-plus is
implemented in the developing world it must not divert resources from
and decrease the effectiveness of DOTS.